Appointment booking for Dr. Cheryl Mensah, MD is currently not available.Dr. Cheryl Mensah, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Cheryl Mensah, MD (she/her) is a Oncologist in New York, NY with over 12 years of experience. What is your opinion of Dr. Cheryl Mensah, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 12 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Cheryl Mensah, MD has received over $50,338 which includes payments from the following companies:
$42,525.00 from Vertex Pharmaceuticals Incorporated
$5,641.09 from Chiesi USA, Inc.
$585.81 from Rigel Pharmaceuticals, Inc.
$389.20 from Novartis Pharmaceuticals Corporation
$254.81 from Celgene Corporation
$159.56 from Daiichi Sankyo Inc.
$140.00 from Agios Pharmaceuticals, Inc.
$133.43 from Amgen Inc.
$124.70 from GENZYME CORPORATION
$106.62 from Alexion Pharmaceuticals, Inc.
$57.60 from Shire North American Group Inc
$56.94 from Janssen Biotech, Inc.
$33.29 from Exelixis Inc.
$26.19 from AMAG Pharmaceuticals, Inc.
$23.23 from Incyte Corporation
$22.23 from Teva Pharmaceuticals USA, Inc.
$22.19 from Octapharma USA, Inc.
$18.80 from AbbVie, Inc.
$18.19 from Dova Pharmaceuticals
Payments received by Dr. Cheryl Mensah, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!